MULTILAYER-CELL-FACTORY-SYSTEM

In recent years, the biopharmaceutical industry has demonstrated vigorous development momentum, with cell culture technology being increasingly widely applied, especially in fields such as monoclonal antibodies and viral vaccines. Among various cell culture containers, the cell factory has gained significant popularity due to its unique advantages, making it the preferred choice for large-scale cell culture.

In today's rapidly evolving biopharmaceutical landscape, despite the emergence of new technologies like single-use bioreactors, the multilayer cell factory maintains an irreplaceable position in vaccine production. This is especially true during responses to large-scale pandemics (like COVID-19), thanks to its unique and well-established advantages.

As biomanufacturing continues to scale from lab to production, stability, scalability, and traceability have become central to process optimization. The Multilayer Cell Factory System, once viewed merely as a culture vessel, is now evolving into an integrated, intelligent, and closed platform that anchors modern adherent cell culture processes.